rss
Br J Ophthalmol 2008;92:131-134 doi:10.1136/bjo.2007.126789
  • Original Article
    • Laboratory science

Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy

  1. B Boyle1,
  2. K Korányi2,
  3. A Patocs3,
  4. I Liko4,
  5. A Szappanos1,
  6. R Bertalan1,
  7. K Racz1,
  8. C Balazs5
  1. 1
    Second Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary
  2. 2
    Department of Ophthalmology, National Institute of Neurosurgery, Budapest, Hungary
  3. 3
    Molecular Medicine Research Group, Hungarian Academy of Sciences, Budapest, Hungary
  4. 4
    Gedeon Richter Ltd, Budapest, Hungary
  5. 5
    Endocrine Centre of Polyclinic of the Hospitaller Brothers of St. John of God, Budapest, Hungary
  1. B Boyle, 2nd Department of Medicine, Semmelweis University, Szentkirályi st. 46. H-1088 Budapest, Hungary; belema.boyle{at}gmail.com
  • Accepted 18 August 2007

Abstract

Background/aims: Glucocorticoids have an important role in the regulation of the immune system, and alterations in glucocorticoid signaling may have an impact on the pathophysiology of autoimmune and inflammatory disorders. Because polymorphisms of the glucocorticoid receptor (GR) gene, including the N363S, ER22/23EK, A3669G and BclI variants were found to influence glucocorticoid signalling, we examined whether these polymorphisms could be associated with the development or clinical manifestations of Graves ophthalmopathy (GO).

Methods: The carrier and allelic frequencies of the N363S, ER22/23EK, A3669G, and BclI polymorphisms of the GR were determined in 95 Hungarian outpatients with GO and 160 healthy controls.

Results: No significant changes were found in carrier frequencies of the four polymorphisms between GO patients and healthy controls. However, when GO patients were divided into two subgroups (American Thyroid Association Committee, ATA I–II vs ATA III or greater), the frequency of the polymorphic BclI allele was significantly higher in patients with ATA I–II compared with those with ATA III or more (p = 0.009).

Conclusion: The significant association between the frequency of the polymorphic BclI allele and ATA stage distribution suggests that this polymorphism of the GR gene may affect clinical manifestations of GO, presumably due to an increased signaling of endogenous glucocorticoids.

Footnotes

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF

Services

  1. Email this link to a friend
  2. Alert me when this article is cited
  3. Alert me if a correction is posted
  4. Alert me when eletters are published
  5. Article Usage Statistics
  6. Similar articles in this journal
  7. Similar articles in Web of Science
  8. Similar articles in PubMed
  9. Add article to my folders
  10. Download to citation manager
  11. Request permissions

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.